The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 556.32%. However, over the last six months, the performance has been weaker by 872.05%. The price of TOI increased 17.67% over the last 30 days. And in the last five days, it has surged by 24.21%.
Oncology Institute Inc (TOI) stock is currently valued at $3.13. During the last session, the stock experienced a remarkable rise, reaching $7.0 after opening at $3.13. The stock briefly dropped to $7.0 before ultimately closing at $2.87.
Oncology Institute Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $3.50 on 04/24/25, while the lowest price for the same duration was marked at $0.13 on 11/21/24.
52-week price history of TOI Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Oncology Institute Inc’s current trading price is -10.57% away from its 52-week high, while its distance from the 52-week low is 2398.00%. The stock’s price range during this period has varied between$0.13 and $3.50. The Oncology Institute Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.65 million for the day, a figure considerably higher than their average daily volume of 1.88 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Oncology Institute Inc (TOI) has experienced a quarterly rise of 99.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 287.69M and boasts a workforce of 825 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.02, with a change in price of +2.17. Similarly, Oncology Institute Inc recorded 1,458,717 in trading volume during the last 100 days, posting a change of +225.67%.
TOI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TOI stands at 20.18. Similarly, the long-term debt-to-equity ratio is also 18.83.
TOI Stock Stochastic Average
Oncology Institute Inc’s raw stochastic average for the past 50 days is presently 75.59%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 96.54%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 78.78% and 66.43%, respectively.
